Pain Medicine
Celiac Plexus Block with versus without Botulinum Toxin Type A for Pancreatic Cancer Pain: A Retrospective Comparative Study
Abstract Objective To evaluate whether the addition of botulinum toxin type A (BTX) to celiac plexus block (CPB) is associated with improved analgesic outcomes in patients with pancreatic cancer pain. Design Retrospective observational study. Setting Single-center tertiary hospital. Subjects A total of 60 patients with pancreatic cancer pain who underwent fluoroscopy-guided CPB between January 2022 and November 2025. Methods Patients were divided into CPB only (n = 34) and CPB with BTX (n = 26) groups. Pain intensi …